文献速递哮喘

哮喘控制与哮喘费用的关联:基层医疗纵向研究

Association between asthma control and asthma cost: Results from a longitudinal study in a primary care setting.
PubMed 文献 · Respirology · 2016-11-10

该研究纳入2008至2013年两家综合诊所哮喘护理项目的736例患者,基于ACT评分比较控制良好与欠佳患者的直接和间接费用,并用GEE纵向建模。结果显示控制良好者每次就诊药费多48新元(P<0.01),但总费用少65新元(P<0.01),肥胖患者节省更明显(42新元,P<0.05)。

要点

  • ACT≥20分的良好控制与每次就诊总费用降低65新元相关。
  • 良好控制者药费增加48新元,但总费用仍下降。
  • 肥胖患者从控制中获得的费用节省大于正常体重者。

核心结论

  • 最佳哮喘控制与医疗费用降低相关。

研究设计与样本

  • 纵向研究,2008至2013年两家综合诊所哮喘护理项目共纳入736例患者。
  • 直接费用来自综合诊所就诊频次、药物费用和住院,间接费用来自急性发作导致的工作日损失。
  • 采用广义估计方程(GEE)纵向建模总医疗支出相关因素。

主要发现

  • 哮喘控制良好者每次就诊哮喘药物费用比控制欠佳者多48新元(36美元)(P<0.01)。
  • 哮喘控制良好者每次就诊总费用比控制欠佳者少65新元(48美元)(P<0.01)。
  • 肥胖患者实现哮喘控制的费用节省大于正常体重患者(42新元,相当于31美元;P<0.05)。

关键数值与推荐

  • ACT评分20分及以上提示哮喘控制良好。
  • 费用比较基于每次医生就诊。

临床怎么用

  • 有效治疗方案除追求哮喘控制外,还应考虑体重控制等可干预因素以降低哮喘费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Asthma control can be assessed with the Asthma Control Test (ACT) and a score of 20 or higher indicates good asthma control. Patients pay for their consultation and treatment in the fee-for-service primary healthcare system in Singapore. We hypothesized that achieving asthma control would result in lower asthma costs through reduced acute exacerbations, fewer physician consultations and lower lost productivity. The study compared the healthcare costs of patients who achieved asthma control and those with suboptimal asthma control based on ACT scores. Factors influencing asthma control and healthcare expenditure over time were also examined. METHODS: A total of 736 patients were enrolled into an asthma care programme in two polyclinics during 2008 and 2013. Direct costs of asthma management were derived from the frequency of polyclinic consultations, medication costs and hospitalization. Indirect costs were estimated from lost workdays due to exacerbations. The generalized estimating equation (GEE) approach was used to longitudinally model the factors associated with total healthcare expenditure. RESULTS: Patients with asthma control spent S$48 (US$36) more per doctor visit on asthma drugs (P < 0.01) but incurred S$65 (US$48) less per doctor visit in total costs (P < 0.01) than those with suboptimal asthma control. The savings from achieving asthma control for obese patients were greater than for normal-weight patients (S$42 or the equivalent of US$31; P < 0.05). CONCLUSION: Optimal asthma control was associated with reduced healthcare costs. An effective treatment regimen should also consider other modifiable factors such as weight control to achieve asthma control and eventually reduce asthma costs.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Nguyen HV, Nadkarni NV, Sankari U, et al. Association between asthma control and asthma cost: Results from a longitudinal study in a primary care setting. Respirology. 2016. PMID: 27862645. doi:10.1111/resp.12930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。